JD-13
JD-13 is a HPV-1 inhibitor and anti-proliferative agent against cancer cells. JD-13 downregulates the expression of HSV-1 DNA polymerase-related genes UL30 and UL42, and inhibits viral replication. JD-13 induces apoptosis (apoptosis) in colorectal cancer cells and suppresses their colony formation. JD-13 can be applied to the research of herpes simplex virus infection and related diseases including colorectal cancer, lung cancer, esophageal cancer and breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 2969172-58-3
- Formula: C25H32N4O3
- Molecular Weight:436.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
JD-13 (0.125-0.5 μM; 72 h) potently inhibits acyclovir-resistant herpes simplex virus type 1 (HSV-1-153) infection in Vero cells, with near-complete inhibition at concentrations of 0.125, 0.25, and 0.5 μM[1].
JD-13 (0.125-0.5 μM; 24 h) effectively reduces herpes simplex virus type 1 genomic DNA copy numbers in Vero cells, with stronger activity than acyclovir at concentrations of 0.125, 0.25, and 0.5 μM after 24 hours of incubation[1].
JD-13 (0.5 μM) most potently inhibits herpes simplex virus type 1 protein expression in Vero cells when administered within the first 6 hours of infection[1].
JD-13 (0.5 μM; 2-6 h) downregulates the expression of herpes simplex virus type 1 DNA polymerase-related genes UL30 and UL42 in Vero cells, with significant inhibition observed at 4 hours for UL42 and 6 hours for both UL30 and UL42[1].
JD-13 (20-80 nM; 24 h) inhibits the colony formation ability of HCT116 and SW620 human colon cancer cells after a 24-hour treatment followed by 14 days of drug-free culture[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Vero cells
-
Concentration:0.5 μM
-
Incubation Time:24 h (added at 0 h post-infection); 21 h (added at 3 h post-infection); 18 h (added at 6 h post-infection); 15 h (added at 9 h post-infection); 12 h (added at 12 h post-infection)
-
Result:Showed the strongest inhibitory effect on the expression of HSV-1 proteins gB and ICP0 when added within 6 hours post-infection.
Exhibited weakened inhibitory effect when added at 9 or 12 hours post-infection.
-
Cell Line:Vero cells
-
Concentration:0.5 μM
-
Incubation Time:2 h; 4 h; 6 h
-
Result:Had no significant effect on the expression of UL30 and UL42 at 2 hours post-treatment.
Significantly downregulated UL42 expression at 4 hours post-treatment.
Significantly downregulated both UL30 and UL42 expression at 6 hours post-treatment.
-
Cell Line:HCT116, SW620, A549, Eca109, MDA-MB-231
-
Concentration:Variable concentrations
-
Incubation Time:48 h
-
Result:Inhibited the viability of HCT116, SW620, A549, Eca109, and MDA-MB-231 cells in a concentration-dependent manner.
Had IC50 values of 35.49 nM for HCT116, 24.64 nM for SW620, 36.19 nM for A549, 35.82 nM for Eca109, and 52.14 nM for MDA-MB-231.
Showed significantly lower IC50 values than the reference compound JD-02.
-
Cell Line:HCT116, SW620
-
Concentration:20-80 nM
-
Incubation Time:24 h (followed by 14 days of drug-free culture)
-
Result:Significantly reduced the size and number of cell colonies formed by HCT116 and SW620 cells compared to the control group.
-
Cell Line:HCT116, SW620
-
Concentration:Low, medium, and high doses
-
Incubation Time:48 h
-
Result:Induced typical apoptotic characteristics including cell shrinkage, cytoplasmic condensation, highly condensed and marginalized nuclear chromatin, fragmented nuclei, and apoptotic bodies compared to the blank control group.
Increased the number of cells with strong blue fluorescent apoptotic nuclei in a concentration-dependent manner.
Chemical Information
-
CAS No. 2969172-58-3
-
Molecular Weight 436.55
-
Formula C25H32N4O3
-
SMILES
O=C(C1=CC=C(N2N=C(C)C3=C2CC(C)(C)CC3=O)C=C1NC45CCC(CC4)(CC5)O)N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)